Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC

Triple-negative breast cancer (TNBC) is associated with high recurrence rates, high incidence of distant metastases, and poor overall survival (OS). Taxane and anthracycline-containing chemotherapy (CT) is currently the main systemic treatment option for TNBC, while platinum-based chemotherapy showe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Paola, Scatena, Cristian, Ghilli, Matteo, Bargagna, Irene, Lorenzini, Giulia, Nicolini, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836182/
https://www.ncbi.nlm.nih.gov/pubmed/35163586
http://dx.doi.org/10.3390/ijms23031665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836182/
https://www.ncbi.nlm.nih.gov/pubmed/35163586
http://dx.doi.org/10.3390/ijms23031665

Ejemplares similares